Transcriptomics

Dataset Information

0

Molecular determinants of response to high dose androgen therapy in prostate cancer


ABSTRACT: Clinical trials of high-dose androgen therapy for prostate cancer have shown promising efficacy but are limited by lack of criteria to identify likely responders. To elucidate factors that govern the growth-repressive effects of high-dose androgens we applied an unbiased integrative approach utilizing genetic screens and transcriptional profiling of prostate cancer cells with or without demonstrated phenotypic sensitivity to androgen-mediated growth repression. Through this comprehensive analysis, we identified genetic events and related signaling networks that determine the response to both high-dose androgen and androgen withdrawal. We applied these findings to develop a gene signature that may serve as an early indicator of treatment response and identify men with tumors amenable to high dose androgen therapy.

ORGANISM(S): Homo sapiens

PROVIDER: GSE135879 | GEO | 2019/12/02

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA560394 | ENA
2016-06-30 | E-GEOD-61630 | biostudies-arrayexpress
2022-11-21 | GSE211639 | GEO
2022-03-01 | PXD002913 | Pride
2023-02-17 | PXD036962 | Pride
2024-07-09 | GSE262744 | GEO
2024-07-09 | GSE247592 | GEO
2024-07-09 | GSE247591 | GEO
2015-03-28 | GSE56289 | GEO
2012-06-20 | GSE32982 | GEO